MUNICH--(BUSINESS WIRE)--Definiens, the global leader in image analysis for digital pathology and diagnostics, announced today that it has signed an agreement with INSERM Transfert to sponsor the worldwide consortium for the validation of the Immunoscore, a new approach to cancer therapy that has been called “transformational.”
Help employers find you! Check out all the jobs and post your resume.
